GPTHEALTH

GPT Healthcare, a small-cap player in the hospital and healthcare services industry, a shift in technical trends from sideways to mildly bearish. The company's current stock price stands at 159.50, slightly up from the previous close of 158.70. Over the past year, GPT Healthcare has experienced a decline of 18.87%, underperforming against the BSE500 index. The stock's performance has been characterized by a negative financial outlook, with a reported PAT of Rs 7.68 crore for Q1 FY25-26, reflecting a significant drop of 38.5% compared to the previous quarter's average. Institutional investor participation has also seen a decrease, with a 1.55% reduction in stake over the last quarter. Despite these challenges, GPT Healthcare maintains a low debt-to-equity ratio and a high management efficiency, indicated by a ROCE of 28.30%. The stock is currently trading at a discount relative to its peers, with a price-to-book value of 5.3.